share_log

Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know

Critical Insights From Roivant Sciences Analyst Ratings: What You Need To Know

來自Roivant Sciences分析師評級的關鍵見解:你需要知道的
Benzinga ·  04/22 23:01
7 analysts have expressed a variety of opinions on Roivant Sciences (NASDAQ:ROIV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中,有7位分析師對Roivant Sciences(納斯達克股票代碼:ROIV)表達了各種觀點,從看漲到看跌,提出了各種各樣的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級,簡要介紹了過去30天中不斷變化的情緒,並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $18.0, with a high estimate of $23.00 and a low estimate of $15.00. Marking an increase of 10.77%, the current average surpasses the previous average price target of $16.25.
分析師對12個月目標股價的評估提供了更多見解,顯示平均目標價爲18.0美元,最高估計爲23.00美元,低估值爲15.00美元。當前的平均價格上漲了10.77%,超過了之前的平均目標股價16.25美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細明細
The analysis of recent analyst...
對分析師最...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論